A Deubiquitinase That Regulates Type I Interferon Production

Nobuhiko Kayagaki,Qui Phung,Salina Chan,Ruchir Chaudhari,Casey Quan,Karen M. O'Rourke,Michael Eby,Eric Pietras,Genhong Cheng,J. Fernando Bazan,Zemin Zhang,David Arnott,Vishva M. Dixit

DOI: https://doi.org/10.1126/science.1145918

IF: 56.9

2007-01-01

Science

Abstract:Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A (DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA–based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor–associated factor 3 (TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin ligase that preferentially assembled lysine-63–linked polyubiquitin chains. DUBA selectively cleaved the lysine-63–linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANK-binding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.